• Skip to primary navigation
  • Skip to main content
  • Skip to footer
0031 20 237 36 00
Follow us on Linked

K2

German translation
English translation
Polish translation

k2-d3

German translation
English translation
Polish translation

Whitelabel

German translation
English translation
Polish translation
  • Home
  • Branded
    Supplements
    • Liposomal NutraCups
    • Liposomal PEA NutraCups
  • White Label
    Supplements
    • Product overview
    • Liposomal CBD
    • Liposomal Melatonin
    • Liposomal CBD-Melatonin
    • Liposomal DHA
    • Liposomal DHA-Lutein
    • Liposomal vitamin D3
    • Liposomal vitamin K2
    • Liposomal vitamin K2-D3
LIPOSOMA Nutraceuticals

LIPOSOMA Nutraceuticals

  • Benefits of
    Liposomes
    • Liposomes as building blocks
    • Liposomes as delivery system
    • Literature
  • About
    LIPOSOMA
    • About LIPOSOMA
    • News & Scientific developments
  • Contact Us
  • Benefits of
    Liposomes
    • Liposomes as building blocks
    • Liposomes as delivery system
    • Literature
  • About
    LIPOSOMA
    • About LIPOSOMA
    • News & Scientific developments
  • Contact Us

Literature

HOME \ Literature

Sources

Our team is committed to scientific excellence

Liposome technology

Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., Nejati-Koshki, K. (2013). Liposome: classification, preparation, and applications. Nanoscale Research Letters 8(1), 102. doi: 10.1186/1556-276X-8-102.

Briuglia, M.L., Rotella, C., McFarlane, A., Lamprou, D.A. (2015). Influence of cholesterol on liposome stability and on in vitro drug release. Drug Delivery and Translational Research 5(3), 231-42. doi: 10.1007/s13346-015-0220-8.

Chen, W., Zou, M., Ma, X., Lv, R., Ding, T., Liu, D. (2019). Co-Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity. Journal of Food Science 84(1), 111-120. doi: 10.1111/1750-3841.14405.

Kraft, J.C., Freeling, J.P., Wang, Z., & Ho R.J.Y. (2014). Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. Journal of Pharmaceutical Sciences 103(1), 29–52.

Bioavailability of active compounds

Martinez, M.N., Amidon, G.L. (2002). A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Journal of Clinical Pharmacology 42(6), 620-43.

Takahashi, M., Uechi, S., Takara, K., Asikin, Y., & Wada, K. (2009). Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin. Journal of Agricultural and Food Chemistry 57(19), 9141–9146.

Wajda, R., Zirkel, J., Schaffer, T. (2007). Increase of bioavailability of coenzyme Q(10) and vitamin E. Journal of Medicinal Food 10(4), 731-4.

DHA

Sun, G. Y., Simonyi, A., Fritsche, K. L., Chuang, D. Y., Hannink, M., Gu, Z., Greenlief, C. M., Yao, J. K., Lee, J. C., & Beversdorf, D. Q. (2018). Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins, leukotrienes, and essential fatty acids 136, 3–13. doi: 10.1016/j.plefa.2017.03.006.

Weiser, M. J., Butt, C. M., & Mohajeri, M. H. (2016). Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients 8(2), 99. doi: 10.3390/nu8020099.

PEA

Davis, M. P., Behm, B., Mehta, Z., & Fernandez, C. (2019). The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. The American journal of hospice & palliative care 36(12), 1134–1154. doi: 10.1177/1049909119850807.

Mattace Raso, G., Russo, R., Calignano, A., & Meli, R. (2014). Palmitoylethanolamide in CNS health and disease. Pharmacological research 86, 32–41. doi: 10.1016/j.phrs.2014.05.006.

Lutein

Mares J. (2016). Lutein and Zeaxanthin Isomers in Eye Health and Disease. Annual review of nutrition 36, 571–602. doi: 10.1146/annurev-nutr-071715-051110.

Ranard, K. M., Jeon, S., Mohn, E. S., Griffiths, J. C., Johnson, E. J., & Erdman, J. W., Jr (2017). Dietary guidance for lutein: consideration for intake recommendations is scientifically supported. European journal of nutrition, 56(Suppl 3), 37–42. doi: 10.1007/s00394-017-1580-2.

Melatonin

Andersen, L. P., Werner, M. U., Rosenkilde, M. M., Harpsøe, N. G., Fuglsang, H., Rosenberg, J., & Gögenur, I. (2016). Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC pharmacology & toxicology 17, 8. doi: 10.1186/s40360-016-0052-2.

Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R. Y., Xu, D. P., & Li, H. B. (2017). Dietary Sources and Bioactivities of Melatonin. Nutrients 9(4), 367. doi: 10.3390/nu9040367

CBD

Fraguas-Sánchez, A. I., & Torres-Suárez, A. I. (2018). Medical Use of Cannabinoids. Drugs 78(16), 1665–1703. doi: 10.1007/s40265-018-0996-1.

Lucas, C. J., Galettis, P., & Schneider, J. (2018). The pharmacokinetics and the pharmacodynamics of cannabinoids. British journal of clinical pharmacology 84(11), 2477–2482. doi: 10.1111/bcp.13710.

Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., Laezza, C., & Bifulco, M. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacology & therapeutics 175, 133–150. doi: 10.1016/j.pharmthera.2017.02.041.

Would you like to learn more? Give us a call on 0031 20 237 36 00

Footer

Navigation

  • Home
  • Branded Supplements
  • Liposomal NutraCups
  • Liposomal PEA NutraCups
  • White Label Supplements
  • Product overview
  • Liposomal CBD
  • Liposomal Melatonin
  • Liposomal CBD-Melatonin
  • Liposomal DHA
  • Liposomal DHA-Lutein
  • Liposomal vitamin D3
  • Liposomal vitamin K2
  • Liposomal vitamin K2-D3
  • Benefits of Liposomes
  • Liposomes as building blocks
  • Liposomes as delivery system
  • Literature
  • About LIPOSOMA
  • Contact Us

Contact us

Logo Liposoma Nutraceuticals

    LIPOSOMA HEALTH

  • Science Park 408
  • 1098 XH AMSTERDAM
  • The Netherlands
  • VAT: NL8524.12.551.B01
  • Commercial Chamber: 73881155
  • Phone: +31 (0)20 237 3600
    Follow us on Linked
© 2021 Liposoma BV - visit Liposomatechnology.com for corporate information and Liposoma's three divisions.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
This website uses cookies to ensure you get the best experience. By using our website you agree to our Cookie Policy. . Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

NOW AVAILABLE

White Label Liposomal Vitamin D3

Order now before February 28, 2021
Available:as finished product capsules and liquid or bulk capsules.
Lead Time6 weeks, MOQ 1000 jars.